- Home
- ANGO vs HRZN Comparison
ANGO vs HRZN Comparison
Compare ANGO & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- HRZN
- Stock Information
- Founded
- ANGO 1988
- HRZN 2008
- Country
- ANGO United States
- HRZN United States
- Employees
- ANGO N/A
- HRZN N/A
- Industry
- ANGO Medical/Dental Instruments
- HRZN Finance/Investors Services
- Sector
- ANGO Health Care
- HRZN Finance
- Exchange
- ANGO Nasdaq
- HRZN Nasdaq
- Market Cap
- ANGO 400.8M
- HRZN 324.5M
- IPO Year
- ANGO 2004
- HRZN 2010
- Fundamental
- Price
- ANGO $8.56
- HRZN $7.68
- Analyst Decision
- ANGO Strong Buy
- HRZN Hold
- Analyst Count
- ANGO 3
- HRZN 4
- Target Price
- ANGO $19.00
- HRZN $9.19
- AVG Volume (30 Days)
- ANGO 836.6K
- HRZN 484.0K
- Earning Date
- ANGO 07-15-2025
- HRZN 08-07-2025
- Dividend Yield
- ANGO N/A
- HRZN 17.19%
- EPS Growth
- ANGO N/A
- HRZN N/A
- EPS
- ANGO N/A
- HRZN N/A
- Revenue
- ANGO $292,498,000.00
- HRZN $98,302,000.00
- Revenue This Year
- ANGO $6.31
- HRZN $1.42
- Revenue Next Year
- ANGO $7.35
- HRZN $4.42
- P/E Ratio
- ANGO N/A
- HRZN N/A
- Revenue Growth
- ANGO N/A
- HRZN N/A
- 52 Week Low
- ANGO $5.83
- HRZN $7.09
- 52 Week High
- ANGO $13.50
- HRZN $11.73
- Technical
- Relative Strength Index (RSI)
- ANGO 35.78
- HRZN 41.12
- Support Level
- ANGO $8.91
- HRZN $8.04
- Resistance Level
- ANGO $9.32
- HRZN $8.27
- Average True Range (ATR)
- ANGO 0.50
- HRZN 0.22
- MACD
- ANGO -0.00
- HRZN -0.07
- Stochastic Oscillator
- ANGO 7.44
- HRZN 9.30
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.